Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (R43)

Post Date

June 10th 2011

Application Due Date

October 11th 2011

Funding Opportunity Number

RFA-AR-12-006

CFDA Number(s)

93.846

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

Small Businesses

Funding

• Estimated Total Funding:

  $1500000

• Award Range:

  $None - $300000

Grant Description

This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose preclinical studies to advance the development of biomarkers or treatments for rare musculoskeletal, rheumatic or skin diseases. Rare diseases have a prevalence of fewer than 200,000 affected individuals in the United States. Also eligible for potential funding through this initiative are studies of FDA-designated orphan products for musculoskeletal, rheumatic or skin diseases. See the NIAMS Long-Range Plan for more information about NIAMS research interests (http://www.niams.nih.gov/About_Us/Mission_and_Purpose/long_range.asp).

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-12-006.html